Tech Company Financing Transactions

Igenica Funding Round

5AM Ventures, OrbiMed and The Column Group participated in a $10.3 million funding round for Igenica. The round closed on 12/31/2012.

Transaction Overview

Company Name
Igenica
Announced On
12/31/2012
Transaction Type
Venture Equity
Amount
$10,250,000
Round
Undisclosed
Investors

5AM Ventures (John Diekman)

OrbiMed (Carl Gordon)

The Column Group (David Goeddel)

Third Rock Ventures (Mark Goldsmith)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
863 Mitten Rd. 102
Burlingame, CA 94010
USA
Phone
(650) 231-4320
Website
www.igenica.com
Email Address
[email protected]
Overview
Igenica is a biopharmaceutical company developing antibody-based therapeutics for the treatment of cancer.
Profile
Igenica LinkedIn Company Profile
Social Media
Igenica Company Twitter Account
Company News
Igenica News
Facebook
Igenica on Facebook
YouTube
Igenica on YouTube

Management Team

Title
Name
Email & Social
Chief Financial Officer
Hans van Houte
  Hans van Houte LinkedIn Profile  Hans van Houte Twitter Account  Hans van Houte News  Hans van Houte on Facebook
VP - Bus. Development
John Celebi
  John Celebi LinkedIn Profile  John Celebi Twitter Account  John Celebi News  John Celebi on Facebook

 

 

Browse more venture capital transactions:

Prev: 12/31/2012: SocMetrics venture capital transaction
Next: 12/31/2012: NeoChord venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.